, Volume 48, Issue 1, pp 17–27 | Cite as

Rapid microspectrofluorometric studies in EL2 cells following intracellular accumulation of dibenzocarbazoles

  • Michel Deumie
  • Elli Kohen
  • Pierre Viallet
  • Cahide Kohen
  • Jean-Marie Salmon


Microspectrofluorometric observations were carried out in EL2 ascites cancer cells and dibenzo(a,e)fluoranthene (diB(a,e)F)-grown EL2 cells, following treatment (5 min) with three dibenzocarbazoles (1,2,7,8; 1,2,5,6 and 3,4,5,6). After microinjection of glucose-6-P leading to reduction of NAD(P), a sequence of difference spectra (after substrate minus before) is recorded. In dibenzocarbazole-untreated cells, maximum NAD(P) reduction (emission maximum at 465–475 nm) is attained within 5 s, followed by a gradual return to initial fluorescence within 20 to 200 s (faster in the diB(a,e)F-grown). In dibenzocarbazole-treated cells there is a rather regular increase in the intensity of the difference spectrum up to ∼ 300–500 s. Initially the increase is more predominant in the region around 460–470 nm, but it gains later prominence in the shorter wavelength region (420–430 nm) characteristic of the hydrocarbon (higher and steadier increase in the 3,4,5,6, dibenzocarbazole-treated diB(a,e)F-grown). Subsequently there is a gradual decrease of fluorescence which may or may not return to initial level. The observed increase spectra require evaluation in terms of possible components (e.g. a mixture of NAD(P)H and hydrocarbon, binding changes, succession of fluorescent metabolites).


Hydrocarbon Short Wavelength Fluoranthene Emission Maximum Steady Increase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Badger, G.M., Cook, J.W., Hewett, C.L., Kennaway, E.L., Kennaway, N.M., Martin, R.H.: The production of cancer by pure hydrocarbones VI. Proc. roy. Soc. B 131, 170–182 (1942)Google Scholar
  2. Boyland, E., Brues, A.M.: The carcinogenic action of dibenzocarbazoles. Proc. roy. Soc. B 122, 429–441 (1937)Google Scholar
  3. Boyland, E., Sims, P.: The metabolism of benz (a) anthracene and dibenz (a, h) anthracene and their 5, 6 epoxy-5, 6-dihydro derivatives by rat liver homogenates. Biochem J. 97, 7–16 (1965)Google Scholar
  4. Buu Hoi, N.P.: New developments in chemical carcinogenesis by polycyclic hydrocarbons and related heterocycles. Cancer Res. 24, 1511–1523 (1964)Google Scholar
  5. Falk, H.L., Kotin, P., Lee, S.S., Nathan, A.: Intermediary metabolism of benzo (a) pyrene in the rat. J. nat. Cancer Inst. 28, 699–724 (1962)Google Scholar
  6. Gelboin, H.V.: A microsome dependent binding of benzo (a) pyrene in DNA. Cancer Res. 29, 1272–1276 (1969)Google Scholar
  7. Gelboin, H.V., Kinoshita, N., Wiebel, F.: Microsomal hydroxylases: induction and role in polycyclic hydrocarbon carcinogenesis and toxicity. Fed. Proc. 31, 1298–1309 (1972)Google Scholar
  8. 7H-Dibenzo (c.g.) carbazole. IARC monographs on the evaluation of carcinogenic risk of the chemical to man. Certain polycyclic aromatic hydrocarbons and heterocyclic compounds. Vol. 3, 260–263. Lyon: International Agency for Research on Cancer, WHO 1973Google Scholar
  9. Kinoshita, A., Shears, B., Gelboin, H.V.: K region and non-K region metabolism of benzo (a) pyrene by rat liver microsomes. Cancer Res. 33, 1937–1944 (1973)Google Scholar
  10. Kirby A.H.M.: The carcinogenic activity of N-ethyl-3:4:5:6-dibenzcarbazole. Biochem. J. 42, V (1948)Google Scholar
  11. Kohen, E., Bengtsson, G., Salmon, J.M. and Kohen, C.: The investigation of critical parameters in the glycolytic response of single living cells by rapid microspectrofluorometric analysis. Mikrochim. Acta. 249 (1976I)Google Scholar
  12. Kohen, E., Hirschberg, J.G., Kohen, C., Wouters, A.W., Pearson, A., Salmon, J.M., Thorell, B.: Multichannel microspectrofluorometry for topographic and spectral analysis of NAD(P)H fluorescence in single living cells. Biochim. biophys. Acta (Amst.) 396, 149–154 (1975a)Google Scholar
  13. Kohen, E., Kohen, C., Salmon, J.M., Bengtsson, G., Thorell, B.: Rapid microspectrofluorometry for biochemical and metabolic studies in single living cells. Biochim. biophys. Acta (Amst.) 362, 575–583 (1974a)Google Scholar
  14. Kohen, E., Salmon, J.M., Viallet, P., Kohen, C., Deumie, M.: The UV fading of hydrocarbon fluorescence and its prevention for observation in single living cells. Histochemistry 44, 357–361 (1975b)Google Scholar
  15. Kohen, E., Thorell, B., Kohen, C., Salmon, J.M.: Studies on metabolic events in localized compartments of the living cells by rapid microspectro-fluorometry. Adv. biol. med. Phys. 15, 271–297 (1974b)Google Scholar
  16. Lacassagne, A., Buu Hoi, N.P., Zajdela, F., Jacquignon, P., Perin, F.: Relations entre structure moleculaire et activite cancerogene chez les benzopyridocarbazoles et les composes polycycliques analogues. C.R. Acad. Sci. (Paris) 257, 818–822 (1963)Google Scholar
  17. Lacassagne, A., Buu Hoi, N.P., Zajdela, F., Perin, F., Jacquignon, P.: A new family of potent carcinogens: benzopyridocarbazoles. Nature (Lond.) 191 1005–1006 (1961)Google Scholar
  18. Salmon, J.M., Kohen, E., Kohen, C., Bengtsson, G.: A Microspectrofluoremetric approach for the study of benzo (a) pyrene and dibenzo (a, h) anthracene metabolization in single living cells. Histochemistry 42, 61–74 (1974a)Google Scholar
  19. Salmon, J.M., Kohen, E., Kohen, C., Bengtsson, G.: The effect of intracellular oxygen on the metabolization of benzo (a) pyrene and benzo (k) fluoranthene. A microspectrofluorometric analysis in single living cells. Histochemistry 42, 75–84 (1974b)Google Scholar
  20. Salmon, J.M., Kohen, E., Kohen, C., Bengtsson, G.: Microspectrofluorometric study of benzo (a) pyrene metabolization in benzo (a) pyrene-grown single living cells. Histochemistry 42, 85–98 (1974c)Google Scholar
  21. Salmon, J.M., Kohen, E., Kohen, C., Viallet, P., Zajdela, F.: A preliminary microspectrofluorometric study of NAD(P) reduction in dibenzo (a, e) fluoranthene-treated single living cells. Histochemistry 47, 291–302 (1976)Google Scholar
  22. Sims, P.: Quanlitative and quantitative studies on the metabolism of a series of aromatic hydrocarbons by rat liver preparations. Biochem. Pharmacol. 19, 795–818 (1970)Google Scholar
  23. Tarbell, D.S., Brooker, E.G., Seifert, P., Vanterpool, A., Claus, C.J., Conway, W.: Studies on the metabolic products from mouse skin after painting with 3,4-benzpyrene. Cancer Res. 16, 37–47 (1956)Google Scholar
  24. Velick, S.F.: Fluorescence spectra and polarization of glyceraldehyde-3-phosphate and lactic dehydrogenase complexes. J. biol. Chem. 233, 1455–1467 (1958)Google Scholar
  25. Watanabe, M., Van Potter, R., Morris, H.P.: Benzpyrene hydroxylase activity and its induction by methylcholantrene in Morris hepatomas, in host livers, in adult liver and in rat liver during development. Cancer Res. 30, 263–273 (1970)Google Scholar
  26. Wattenberg, L.W., Leong, J.L.: Inhibition of the carcinogenic action of benzo(a)pyrene by flavones. Cancer Res. 30, 1922–1925 (1970)Google Scholar
  27. Weigert, F., Mottram, J.C.: The biochemistry of benzpyrene I. A survey and new methods of analysis. Cancer Res. 6, 97–109 (1946)Google Scholar
  28. Winer, A.D., Schwert, G.W., Millar, D.B.S.: VI. Fluorometric measurements of the complex of enzymes and reduced diphosphopyridine nucleotides. J. biol. Chem. 234, 1149–1154 (1959)Google Scholar

Copyright information

© Springer-Verlag 1976

Authors and Affiliations

  • Michel Deumie
    • 1
  • Elli Kohen
    • 1
  • Pierre Viallet
    • 1
  • Cahide Kohen
    • 1
  • Jean-Marie Salmon
    • 1
  1. 1.Papanicolaou Cancer Research InstituteMiamiUSA

Personalised recommendations